Ischemix ischemix.com


Public lists: Pharma Startups (4729)

Ischemix is a privately-held, clinical-phase biotechnology company developing a portfolio of therapeutic compounds for the prevention and treatment of serious cardio-renal conditions. The Company's lead product candidate, CMX-2043, is a chemically-modified natural compound with an excellent safety profile. In a 142-patient international Phase 2a trial in PCI patients, CMX-2043 demonstrated statistical significance in the reduction of biomarkers of cardiac injury. The Company intends to initiate ...Show all

Ischemix is a privately-held, clinical-phase biotechnology company developing a portfolio of therapeutic compounds for the prevention and treatment of serious cardio-renal conditions. The Company's lead product candidate, CMX-2043, is a chemically-mo...Show all

Company (Alive / Active)

Phone: 978-897-5139

Fax:

63 Great Rd

Maynard, 01754
Massachusetts, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Ischemix $6.6M Jun 5, 2014

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Ischemix Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
Undisclosed InvestorsOtherUnattributed
See all 1 investors
There is no Board of Directors data available for this company. Please select another tab.
There is no Competitors data available for this company. Please select another tab.